AXSOME THERAPEUTICS, INC.: net inventory
Net inventory for AXSOME THERAPEUTICS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All AXSOME THERAPEUTICS, INC. financial histories
What this measure means
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
Exact concept: us-gaap:InventoryNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2022-12-31 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 27,938,000 | USD | 2026-02-23 | 10-K · 0001193125-26-064267 |
| At date | 2024-12-31 | 15,732,000 | USD | 2026-02-23 | 10-K · 0001193125-26-064267 |
| At date | 2023-12-31 | 15,135,000 | USD | 2025-02-18 | 10-K · 0000950170-25-022457 |
| At date | 2022-12-31 | 4,320,000 | USD | 2024-02-23 | 10-K · 0000950170-24-019118 |
Related financial histories
- AXSOME THERAPEUTICS, INC.: total assets
- AXSOME THERAPEUTICS, INC.: total liabilities
- AXSOME THERAPEUTICS, INC.: stockholders equity
- AXSOME THERAPEUTICS, INC.: cash and cash equivalents
- AXSOME THERAPEUTICS, INC.: net income or loss
- AXSOME THERAPEUTICS, INC.: operating cash flow
- AXSOME THERAPEUTICS, INC.: capital expenditure payments
- AXSOME THERAPEUTICS, INC.: contract revenue excluding tax
- AXSOME THERAPEUTICS, INC.: financing cash flow
- AXSOME THERAPEUTICS, INC.: investing cash flow
- AXSOME THERAPEUTICS, INC.: retained earnings or deficit
- AXSOME THERAPEUTICS, INC.: basic weighted-average shares
- AXSOME THERAPEUTICS, INC.: diluted weighted-average shares
- AXSOME THERAPEUTICS, INC.: basic earnings per share
- AXSOME THERAPEUTICS, INC.: diluted earnings per share
- AXSOME THERAPEUTICS, INC.: income tax expense or benefit
- AXSOME THERAPEUTICS, INC.: net property, plant and equipment
- AXSOME THERAPEUTICS, INC.: share-based compensation expense
- AXSOME THERAPEUTICS, INC.: operating income or loss
- AXSOME THERAPEUTICS, INC.: current assets
- AXSOME THERAPEUTICS, INC.: interest expense
- AXSOME THERAPEUTICS, INC.: current liabilities
- AXSOME THERAPEUTICS, INC.: current accounts payable
- AXSOME THERAPEUTICS, INC.: goodwill carrying amount
- AXSOME THERAPEUTICS, INC.: net finite-lived intangible assets
- AXSOME THERAPEUTICS, INC.: net current accounts receivable
- AXSOME THERAPEUTICS, INC.: operating expenses
- AXSOME THERAPEUTICS, INC.: selling, general and administrative expense
- AXSOME THERAPEUTICS, INC.: research and development expense
Inspect the source
- Entity
- AXSOME THERAPEUTICS, INC. / CIK 0001579428
- Captured
- 2026-09-19T11:19:11.812Z
- SEC response SHA-256
bb534249e79901f14ef56a7cde4d7cfc00d4e7cc31cc09f237146d8a497ea5fc
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001579428.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))